89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details
臨床試験数 : 39 / 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00005906 (ClinicalTrials.gov) | June 2000 | 9/6/2000 | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | Lymphangioleiomyomatosis;Lymphangiomyomas;Pleural Effusions;Ascites | Drug: Octreotide | National Heart, Lung, and Blood Institute (NHLBI) | NULL | Completed | 18 Years | 65 Years | Female | 4 | Phase 2 | United States |